Clinical Trials Directory

Trials / Completed

CompletedNCT01443247

Role of Andi-d in Dengue Fever: a Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The purpose of this study is evaluate the role of anti-d in dengue fever.

Detailed description

This study was conducted in pgimer. Patients presenting with fever and thrombocytopenia in emergency medical opd / medicine opd were screened and all dengue serology positive patients were evaluated for enrolment into the study. We had proposed to enroll 30 patients with diagnosed dengue haemorrhagic fever. the diagnosis of the dengue fever was based upon the clinical history ,general physical examination and the lab tests : thrombocytopenia ( platelet count ≤ 20,000 ) ,and a positive dengue serology. STUDY DESIGN : It was an open label inteventional study . one group of 15 patients ( intervention group ) received platelet support along with injection anti-d in a dose of 50 µg/kg (250IU/kg) intravenously while the other group of 15 ( control group) received platelet support only . a base line platelet count of all the participant of both the study groups was taken and then the level of platelets at 12 , 24 , 36 , and 48hr post treatment initiation was noted. The patients were followed till the time of discharge .

Conditions

Interventions

TypeNameDescription
DRUGanti-dintervention group received injection anti-d in dose of 50 µg/kg (250IU/kg) along with platelet concentrate while control ( non intervention ) group received platelet support only

Timeline

Start date
2010-09-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2011-09-29
Last updated
2011-09-29

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01443247. Inclusion in this directory is not an endorsement.